Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Genzyme Corporation Product Pipeline Analysis

Published by: Global Markets Direct

Published: May. 29, 2008 - 78 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Company Snapshot
2.1 Key Information
2.2 Company Overview
2.3 Financial Performance
2.4 Industry Outlook - Orthopedic Devices
2.5 Industry Outlook - In Vitro Diagnostics
3 Genzyme Corporation Pipeline Products
3.1 Genzyme Corporation Product Pipeline Analysis
3.1.1 Genzyme Corporation Pipeline Products By Equipment Type
3.1.2 Genzyme Corporation Pipeline Products By Development Stage
3.1.3 Genzyme Corporation Pipeline Products By Therapy Area
3.1.4 Genzyme Corporation Pipeline Products By Clinical Trials
3.1.5 Genzyme Corporation Pipeline Products By News Summary
3.2 Synvisc-One
3.2.1 Product Description
3.2.2 Product Status
3.2.3 Clinical Trials
3.2.4 Product Milestone
3.3 Next Generation Synvisc (hylan G-F 20)
3.3.1 Product Description
3.3.2 Product Status
3.3.3 Clinical Trials
3.3.4 Product Milestone
3.4 Carticel II
3.4.1 Product Description
3.4.2 Product Status
3.5 Hylastan
3.5.1 Product Description
3.5.2 Product Status
3.5.3 Clinical Trials
3.5.4 Product Milestone
3.6 Sepragel Ortho
3.6.1 Product Description
3.6.2 Product Status
3.7 Third generation cartilage repair
3.7.1 Product Description
3.7.2 Product Status
3.8 Sepraspray adhesion barrier
3.8.1 Product Description
3.8.2 Product Status
3.8.3 Clinical Trials
3.9 Novel tests for new targeted therapies in hematologic malignancy
3.9.1 Product Description
3.9.2 Product Status
3.10 Candida Rapid Test
3.10.1 Product Description
3.10.2 Product Status
3.11 CLIA waived Flu A & B rapid test
3.11.1 Product Description
3.11.2 Product Status
3.12 C. difficile toxin A & B rapid test
3.12.1 Product Description
3.12.2 Product Status
3.13 Adenovirus rapid test
3.13.1 Product Description
3.13.2 Product Status
4 Business Description
4.1 Business Overview
4.2 Major Products and Services
4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
10.1 Head Office
10.2 Other Locations & Subsidiaries
11 Financial Deals Landscape
11.1 Acquisition
11.1.1 Genzyme Corporation Completes Acquisition Of Bioenvision
11.1.2 Genzyme Acquires Anormed
11.2 Partnership
11.2.1 Genzyme Enters Into Licensing Agreement With Moffitt Cancer Center
11.2.2 Genzyme And Isis Pharmaceuticals Enters Into Co-Marketing Agreement
11.2.3 C. R. Bard Enters Into License Agreement With Genzyme Corporation
11.2.4 Genzyme Enters Into A License Agreement With Massachusetts General Hospital And Dana-Farber Cancer Institute
12 Recent Developments
12.1 Strategy and Business Planning
12.1.1 Jun 07, 2007: Genzyme To Build New Biomanufacturing Plant
12.1.2 Oct 18, 2006: MMV, Genzyme And Broad Institute Collaborate To Discover New Drugs For Malaria
12.2 Product Announcements
12.2.1 Apr 14, 2008 Genzyme Genetics Announces Launch Of Carrier Testing And Prenatal Diagnosis For Spinal Muscular Atrophy
12.2.2 Dec 19, 2007 Genzyme Receives European CE Mark For Single-Treatment Synvisc-One
12.2.3 Nov 13, 2007 Genzyme Corporation Receives FDA Response Letter On Synvisc-One Approval In US To Be Delayed
12.2.4 Nov 13, 2007 Genzyme Receives FDA Response Letter On Synvisc-One
12.2.5 Jul 05, 2007 Genzyme Announces Results Of Clinical Trial For Hylastan
12.2.6 Dec 04, 2006: Genzyme Launches New Genetic Test
12.3 Financial Announcements
12.3.1 Apr 23, 2008: Genzyme Declares Q1 2008 Results
12.3.2 Feb 13, 2008: Genzyme Declares Q4 2007 Results
12.3.3 Oct 24, 2007: Genzyme Declares Q3 2007 Results
12.3.4 Jul 25, 2007: Genzyme Declares Q2 2007 Results
12.3.5 May 29, 2007: Genzyme Approves $1.5 Billion Share Repurchase Program
12.3.6 Apr 25, 2007: Genzyme Raises 2007 Non-GAAP Earnings Forecast
12.3.7 Apr 25, 2007: Genzyme Reports Q1 Results
12.3.8 Feb 14, 2007: Genzyme Provides Strong Outlook For 2007
12.3.9 Feb 14, 2007: Genzyme Declares Q4 2006 Results
12.3.10 Jan 09, 2007: Genzyme Reports Q4 2006 Revenue Growth
12.3.11 Oct 12, 2006: Genzyme Declares Q3 2006 Results
12.3.12 Jul 12, 2006: Genzyme Declares Q2 2006 Results
12.4 Other Significant Developments
12.4.1 Aug 09, 2007: Genzyme Settles Lawsuit Brought By Shareholders
12.4.2 Oct 30, 2006: Genzyme To Challenge Medicare Code And Reimbursement Decision
12.4.3 Aug 31, 2006: Genzyme Commends New Book For Portraying Challenges
13 Appendix
13.1 Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Primary Research
13.1.4 Expert Panel Validation
13.2 Contact Us
13.3 About Global Markets Direct
13.4 Disclaimer
1.1 List of Tables
Table 1: Genzyme Corporation,Key Facts
Table 2: Genzyme Corporation Pipeline Products by Equipment Type
Table 3: Genzyme Corporation Pipeline Products By Development Stage
Table 4: Genzyme Corporation Pipeline Products By Therapy Area
Table 5: Genzyme Corporation Pipeline Products By Clinical Trials
Table 6: Genzyme Corporation Pipeline Products By News Summaries
Table 7: Genzyme Corporation, Key Employees,
Table 8: Genzyme Corporation, Subsidiaries
1.2 List of Figures
Figure 1: Genzyme Corporation Pipeline Products By Equipment Type
Figure 2: Genzyme Corporation Pipeline Products By Equipment Type
Figure 3: Genzyme Corporation Pipeline Products By Clinical Trials
Figure 4: Genzyme Corporation Pipeline Products By News Summary
Figure 5: Global Markets Direct Methodology


Abstract

Summary

This report is an insightful source for data, analysis and strategic insights into a Genzyme Corporation’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope
  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.
Reason to buy
  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.
  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.
  • Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.



Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008